Young–Simpson syndrome (often grouped under the KAT6B-related disorders) is a rare genetic condition present from birth. It affects how the face, brain, skeleton, thyroid gland, heart, and other organs develop. Most children have distinctive facial features (including very narrow eye openings and droopy eyelids), low muscle tone, developmental delay, and sometimes congenital hypothyroidism and heart defects. The condition sits on a spectrum with another KAT6B disorder called genitopatellar syndrome. Many children show features that overlap between the two. NCBI+2PMC+2

Young–Simpson syndrome is a genetic development condition caused by harmful changes in the KAT6B gene. KAT6B helps control how other genes turn on and off during early growth. When KAT6B is changed, the “gene activity switches” do not work correctly. This can change normal growth of the face, brain wiring, bones, thyroid gland, heart, and other organs. Because KAT6B acts in many tissues, children can have features in several body systems at once. The condition usually happens for the first time in the child (a de novo change) and follows an autosomal dominant pattern if passed on. Frontiers+3MedlinePlus+3MedlinePlus+3

Young–Simpson syndrome (SBBYS variant) is a very rare genetic condition in the KAT6B-related disorders spectrum. It causes recognizable facial features (including blepharophimosis and ptosis), developmental delay, low muscle tone, missing or small kneecaps, long thumbs/big toes, and may include heart, thyroid, hearing, dental, and palate differences. It is autosomal dominant, and most cases are due to a new (de novo) pathogenic variant in the KAT6B gene. Diagnosis is clinical plus molecular testing confirming a heterozygous KAT6B variant. There is no single curative drug; care is multidisciplinary and symptom-directed. Genetic Rare Disease Center+4NCBI+4MedlinePlus+4

The KAT6B gene helps control how other genes turn on and off during early development by acetylating histones. When KAT6B is altered, many organs can form differently, leading to the features above. NCBI+1

Other names

Doctors and resources may use several names for the same or closely related condition. Common labels include:

• Say-Barber-Biesecker-Young-Simpson (SBBYS) variant of Ohdo syndrome (often shortened to SBBYS or SBBYSS).

• Blepharophimosis–intellectual disability syndrome, SBBYS type (Orphanet term).

• KAT6B-related disorder (an umbrella term that includes SBBYS/Young–Simpson and genitopatellar syndrome). NCBI+1

Types

Doctors usually talk about two main clinical patterns within the KAT6B spectrum:

1. SBBYS / Young–Simpson pattern – typically shows narrow eye openings (blepharophimosis), droopy eyelids (ptosis), “mask-like” facies, hypothyroidism in many children, developmental delay, and skeletal differences such as missing or small kneecaps and long thumbs/big toes.

2. Genitopatellar syndrome (GPS) – often includes more obvious kneecap underdevelopment, flexion contractures, and genital anomalies; brain differences like agenesis of the corpus callosum are also common.
   Some children sit between these patterns. This is why many experts now talk about KAT6B-related disorders rather than strict boxes. NCBI+1

---

Causes

In a single-gene condition like Young–Simpson syndrome, “causes” means ways KAT6B function can be disrupted. Each item below explains a distinct, evidence-based mechanism or scenario that can produce the syndrome.

1. Loss-of-function variants in KAT6B (such as nonsense or frameshift changes) that reduce or remove KAT6B protein activity. PMC

2. Missense variants that alter a critical amino acid and disturb the protein’s normal shape or binding. PMC

3. Variants clustering in specific exons of KAT6B that correlate with SBBYS/Young–Simpson features. PMC

4. Dominant-negative effect (a faulty KAT6B protein interferes with the normal copy) proposed for some variants. PMC

5. Haploinsufficiency due to deletion of the KAT6B gene (one working copy is not enough). Nature

6. De novo variants arising in the egg or sperm or very early embryo, explaining most sporadic cases. NCBI

7. Autosomal dominant inheritance from an affected parent (less common but possible). Frontiers

8. Chromosomal microdeletions including KAT6B detected on chromosomal microarray. Nature

9. Disruption of histone acetyltransferase activity, which changes how DNA is packaged and how genes are turned on/off. MedlinePlus

10. Altered regulation of developmental genes downstream of KAT6B, affecting brain, bone, and thyroid development. MedlinePlus

11. Skewed acetylation of histone H3 tails at key developmental promoters/enhancers (molecular pathway level). MedlinePlus

12. Impaired formation of transcriptional co-activator complexes that normally include KAT6B. PMC

13. Gene dosage sensitivity—small changes in KAT6B output can have large developmental effects. Nature

14. Mosaicism in the child, where only some cells carry the KAT6B variant (can cause milder or patchy features). NCBI

15. Parental germline mosaicism, where a parent is unaffected but carries the variant in some egg/sperm cells. NCBI

16. Variants that preferentially cause SBBYS pattern (distinct from GPS) because of where the change occurs in KAT6B. PMC

17. Large structural rearrangements that interrupt KAT6B without deleting it entirely. Nature

18. Pathway-level overlap with GPS due to shared KAT6B dysfunction along the same developmental routes. Wiley Online Library

19. Second-hit or modifier gene effects (research suggests variability even with similar KAT6B variants). ScienceDirect

20. Epigenetic mis-programming secondary to reduced histone acetylation, altering broad gene expression programs. MedlinePlus

---

Common symptoms and signs

1. Distinctive eyelids and eye openings. Many children have blepharophimosis (short, narrow eye openings) and ptosis (droopy eyelids). Eyes can look “sleepy,” and the face may seem mask-like with limited facial expression. These features are highly suggestive and help clinicians consider the diagnosis early. Orpha.net+1

2. Characteristic facial shape. Features can include a broad nasal bridge, thin upper lip, long philtrum, and prominent cheeks. These traits vary by child but often form a recognisable pattern for experienced dysmorphologists. Orpha.net

3. Developmental delay and intellectual disability. Most children take longer to sit, stand, talk, and learn. Supportive therapies help progress, but the level of disability ranges from mild to severe. NCBI

4. Low muscle tone (hypotonia). Babies often feel “floppy,” which can delay motor milestones and make feeding harder in infancy. NCBI

5. Congenital hypothyroidism or other thyroid problems. Some children are born with low thyroid hormone and need treatment. Early thyroid testing and treatment support growth and brain development. PubMed+1

6. Heart defects present at birth. Atrial or ventricular septal defects and other structural problems can occur. Many are found on screening echocardiogram in infancy. NCBI

7. Brain structure differences. Some children have agenesis or hypoplasia of the corpus callosum or other brain MRI findings, which can relate to seizures or developmental challenges. Wiley Online Library

8. Hearing loss. Conductive, sensorineural, or mixed hearing loss can appear and should be checked early so speech therapy can start promptly. National Organization for Rare Disorders

9. Feeding difficulties and poor weight gain. Low tone and oral motor issues can cause reflux or slow feeding, which may need nutrition support. NCBI

10. Skeletal differences. These may include small or absent kneecaps, joint contractures, long thumbs or great toes, and other hand/foot changes. Kneecap changes are classically noted in the spectrum. NCBI

11. Genital differences (especially in boys). Cryptorchidism (undescended testes) or hypospadias can be present and may need surgical input. NCBI

12. Cleft palate or high-arched palate. Some children have a split or high palate, which can affect feeding and speech. Orpha.net

13. Dental anomalies. Irregular tooth shape or delayed eruption may occur and benefit from early dental care. ScienceDirect

14. Seizures (in a minority). Seizures can occur and should be evaluated and treated if present. National Organization for Rare Disorders

15. Vision issues. Strabismus, refractive errors, or tear-duct problems can appear and need eye-care follow-up. Orpha.net

---

Diagnostic tests

A) Physical exam

1. Detailed newborn and pediatric exam. A dysmorphology-focused exam notes eyelid shape, facial pattern, limb proportions, and any contractures. These clues guide targeted testing for KAT6B changes. NCBI

2. Growth measurements. Length/height, weight, and head circumference are tracked over time because feeding issues and hypothyroidism can affect growth. NCBI

3. Neurologic exam. Checks tone, reflexes, and motor development to document hypotonia or movement patterns and to plan early therapies. NCBI

4. Cardiac exam. Listening for murmurs and checking oxygen saturation can suggest a congenital heart defect before imaging. NCBI

5. Endocrine/thyroid exam. Palpation and review of symptoms help identify hypothyroidism, which is then confirmed on labs. PubMed

B) Manual/bedside assessments

6. Developmental screening tools (e.g., age-appropriate milestone checklists) to quantify delays and trigger early intervention. NCBI

7. Ophthalmology slit-lamp and eyelid measurements to document blepharophimosis and ptosis and plan surgical or supportive care. Orpha.net

8. Audiology behavioral testing in toddlers/children to estimate hearing and guide hearing aids or therapy. National Organization for Rare Disorders

9. Orthopedic bedside tests for joint range of motion and kneecap tracking, since patellar hypoplasia and contractures are common. NCBI

10. Feeding/oral-motor assessment by speech-language pathology to address poor suck, swallow discoordination, or reflux. NCBI

C) Lab and pathological tests

11. Thyroid function tests (TSH, free T4). These look for congenital or early-onset hypothyroidism so treatment can begin quickly. PubMed

12. Genetic testing: KAT6B sequencing. Next-generation sequencing detects single-letter changes or small insertions/deletions in KAT6B that cause the condition. NCBI

13. Deletion/duplication testing for KAT6B. If sequencing is negative, copy-number testing looks for exon-level or whole-gene loss. Nature

14. Chromosomal microarray (CMA). CMA screens for microdeletions that include KAT6B or other syndromic causes when the picture is unclear. Nature

15. Broad exome/genome testing. When features overlap with other syndromes, exome or genome testing helps confirm KAT6B or identify a different diagnosis. PubMed

D) Electrodiagnostic tests

16. Electroencephalogram (EEG). If there are spells or seizures, EEG helps confirm epilepsy type and guide therapy. National Organization for Rare Disorders

17. Auditory brainstem response (ABR). This objective test measures hearing in infants and nonverbal children. National Organization for Rare Disorders

E) Imaging tests

18. Echocardiogram. A heart ultrasound looks for septal defects and other structural heart issues common in the spectrum. NCBI

19. Brain MRI. MRI checks for agenesis or thinning of the corpus callosum and other brain differences that can affect development or seizures. Wiley Online Library

20. Skeletal imaging. X-rays or targeted views assess patellar hypoplasia/agenesis, spinal alignment, and hand/foot bone differences. NCBI

Non-pharmacological treatments (therapies and other supports)

1. Early intervention therapies (PT/OT/Speech/Feeding)
   Description. From infancy, children benefit from coordinated physical therapy (PT) for low muscle tone and joint stiffness, occupational therapy (OT) for fine-motor and daily skills, speech-language therapy for communication, and feeding therapy for suck-swallow coordination and texture progression. Programs adapt goals as the child grows.
   Purpose. Improve function, independence, and growth.
   Mechanism. Repeated, guided practice strengthens muscles, builds neural pathways for motor planning and speech, and teaches safe feeding patterns. NCBI

2. Developmental pediatrics & individualized education plans (IEP)
   Description. Regular assessments translate needs into school supports (IEP/504), assistive communication, and behavioral strategies.
   Purpose. Maximize learning and participation.
   Mechanism. Structured supports and accommodations reduce barriers created by cognitive and motor challenges. NCBI

3. Vision care & ophthalmology
   Description. Routine eye exams for blepharophimosis/ptosis, lacrimal duct problems, refractive errors, and amblyopia; patching or glasses as needed.
   Purpose. Protect and optimize sight during key developmental windows.
   Mechanism. Correcting optical focus and eyelid position prevents amblyopia and supports visual brain development. NCBI

4. Audiology & hearing support
   Description. Regular hearing tests; hearing aids or other devices if loss is present.
   Purpose. Ensure access to language and learning.
   Mechanism. Amplification delivers clearer sound input to the brain’s language centers. NCBI

5. Cardiology follow-up
   Description. Many children have congenital heart differences; cardiology monitors structure/function and guides activity and procedures.
   Purpose. Prevent heart failure and complications; plan timely interventions.
   Mechanism. Echocardiography and exams detect issues early; treatment follows pediatric standards. NCBI

6. Endocrinology for thyroid health
   Description. Screen and treat congenital or later hypothyroidism; adjust levothyroxine dosing to growth.
   Purpose. Support brain development, energy, and growth.
   Mechanism. Replacing thyroid hormone normalizes metabolism and neurodevelopmental support. NCBI

7. Feeding & nutrition counseling
   Description. Dietitians help with calorie density, safe textures, reflux strategies, and constipation prevention; some children need temporary tube feeding.
   Purpose. Maintain growth, hydration, and comfort.
   Mechanism. Tailored nutrition supports catch-up growth and reduces aspiration/reflux risk. NCBI

8. Orthopedics & physiotherapy for joints/knees/feet
   Description. Missing/small kneecaps, contractures, clubfoot, and hypermobility require bracing, stretching, casting, or surgery timing.
   Purpose. Improve mobility and alignment.
   Mechanism. Mechanical support and stretching remodel soft tissues and optimize gait. NCBI

9. Dental & craniofacial care
   Description. Delayed eruption, hypoplastic teeth, palate issues, and malocclusion need routine dentistry, fluoride, and orthodontic/craniofacial input.
   Purpose. Protect teeth and speech; prevent feeding and airway issues.
   Mechanism. Preventive care plus structural corrections support function and hygiene. NCBI

10. Sleep & breathing management (including possible OSA)
    Description. Snoring, airway anomalies, or hypotonia may cause obstructive sleep apnea; sleep studies and CPAP/ENT care as indicated.
    Purpose. Improve sleep quality, growth, and daytime function.
    Mechanism. Stabilizing the airway reduces apneas and improves oxygenation. NCBI

11. Gastroenterology support (reflux/constipation)
    Description. Positioning, thickened feeds, fiber, and toileting routines; medicines if needed (see drug section).
    Purpose. Reduce discomfort and feeding aversion.
    Mechanism. Non-drug strategies reduce reflux events and improve gut motility. NCBI

12. Speech-language augmentative and alternative communication (AAC)
    Description. Picture boards, tablets, or eye-gaze systems may supplement speech.
    Purpose. Enable communication early—even before speech emerges.
    Mechanism. AAC gives an immediate, reliable way to express needs, which also supports speech development. NCBI

13. Lacrimal duct care & eye surface protection
    Description. Tear-duct obstruction and exposure require eyelid hygiene, massage, and ocular surface protection; referral if infections recur.
    Purpose. Prevent keratitis and discomfort.
    Mechanism. Hygiene plus lubrication maintains a healthy tear film while anatomy is addressed. NCBI

14. Social work & care coordination
    Description. Connects families to home services, mobility devices, and financial supports; coordinates multiple specialists.
    Purpose. Reduce caregiver stress and missed care.
    Mechanism. Navigation support improves adherence and outcomes. NCBI

15. Genetic counseling
    Description. Explains inheritance, recurrence risk, and testing options for family planning, including prenatal/preimplantation testing if the variant is known.
    Purpose. Informed choices and psychosocial support.
    Mechanism. Risk assessment based on autosomal-dominant, usually de novo, KAT6B variants. NCBI

16. Orthotics & mobility aids
    Description. AFOs, knee supports, walkers, or wheelchairs as appropriate.
    Purpose. Promote safe mobility and participation.
    Mechanism. External support improves alignment and reduces energy cost of movement. NCBI

17. Behavioral and mental health supports
    Description. Parenting strategies, behavioral therapy, and caregiver support groups.
    Purpose. Improve coping and daily routines.
    Mechanism. Structured reinforcement and environmental changes reduce frustration and enhance learning. NCBI

18. Regular surveillance plan
    Description. Annual checks for development/education, hearing, vision (amblyopia), thyroid function, contractures/scoliosis; cardiac/renal follow-up as needed.
    Purpose. Detect and treat issues early.
    Mechanism. Scheduled monitoring finds silent problems before they harm growth and learning. NCBI

19. Cleft palate and speech-resonance management
    Description. If a cleft/velopharyngeal issue exists, integrate speech therapy and craniofacial team planning.
    Purpose. Improve feeding and speech clarity.
    Mechanism. Coordinated structural and functional care optimizes resonance and articulation. NCBI

20. Transition planning to adult services
    Description. As teens approach adulthood, plan for adult cardiology, endocrinology, dentistry, and social supports.
    Purpose. Maintain continuity of care.
    Mechanism. Early transition avoids gaps in lifesaving surveillance and therapies. NCBI

---

Drug treatments

Important safety note. There are no FDA-approved medicines that treat Young–Simpson syndrome itself. Medicines are used for specific associated conditions (for example, hypothyroidism, seizures, heart failure, reflux, wheeze). All dosing must be individualized by specialists. Below are examples with FDA label citations to show the evidence base for their approved indications (not disease-specific approval). NCBI

1. Levothyroxine (Synthroid/Levoxyl)
   Class. Thyroid hormone. Dose/Time. Weight-based once daily; neonate/child dosing per thyroid labs. Purpose. Replace missing thyroid hormone. Mechanism. Provides T4 to normalize metabolism and neurodevelopment. Side effects. Overtreatment can cause fast heartbeat, irritability, poor weight gain. FDA Access Data+1

2. Levetiracetam (Keppra / Keppra XR / Spritam)
   Class. Antiseizure. Dose/Time. Age/weight-based; oral or IV options. Purpose. Control seizures if present. Mechanism. Modulates synaptic neurotransmitter release via SV2A binding. Side effects. Sleepiness, mood changes. FDA Access Data+3FDA Access Data+3FDA Access Data+3

3. Furosemide (IV/PO; includes FUROSCIX for SC use in adults)
   Class. Loop diuretic. Purpose. Manage fluid overload in heart disease/edema under cardiology guidance. Mechanism. Blocks Na-K-2Cl in the loop of Henle to increase urine output. Side effects. Electrolyte loss, dehydration; careful pediatric dosing is essential. FDA Access Data+2FDA Access Data+2

4. Enalapril (Epaned oral solution / Vasotec)
   Class. ACE inhibitor. Purpose. Afterload reduction in pediatric heart failure or hypertension per cardiology. Mechanism. Lowers angiotensin II and aldosterone. Side effects. Cough, kidney effects, high potassium; boxed warning for fetal toxicity. FDA Access Data+2FDA Access Data+2

5. Omeprazole (Prilosec)
   Class. Proton-pump inhibitor. Purpose. Acid suppression for reflux that affects feeding/growth. Mechanism. Irreversibly blocks parietal cell H+/K+-ATPase. Side effects. Headache, rare infections with long use; use only when clearly indicated. FDA Access Data+1

6. Albuterol (nebulized solution or HFA inhaler)
   Class. Short-acting β2 agonist. Purpose. Wheeze/bronchospasm relief. Mechanism. Relaxes airway smooth muscle. Side effects. Tremor, fast heartbeat; overuse risks. FDA Access Data+1

7. Somatropin (Genotropin) (select cases with documented growth hormone deficiency; specialist only)
   Class. Recombinant growth hormone. Purpose. Treat proven GH deficiency. Mechanism. Stimulates linear growth and metabolism. Side effects. Intracranial hypertension, slipped capital femoral epiphysis (rare); careful screening needed. FDA Access Data+1

8. Topical ocular lubricants (supportive; OTC monograph products)
   Class. Ocular surface protectants. Purpose. Protect exposed ocular surface when eyelid closure is incomplete. Mechanism. Stabilizes tear film to prevent dryness injury. (General supportive use per ophthalmology; not a drug label citation.) NCBI

9. Polyethylene glycol (PEG 3350) (when constipation resists diet/behavioral plans)
   Class. Osmotic laxative. Purpose. Soften stools to reduce pain and withholding cycles. Mechanism. Holds water in stool. (Use per pediatric GI guidance; label specifics vary by brand.) NCBI

10. Acetaminophen/Ibuprofen (short-term comfort)
    Class. Analgesic/antipyretic; NSAID. Purpose. Pain/fever relief after procedures or with musculoskeletal issues. Mechanism. Central COX modulation (acetaminophen); COX inhibition (ibuprofen). (Standard pediatric use per labels; choose dosing carefully.) NCBI

11. Antibiotic eye or ear drops (as indicated)
    Class. Topical antimicrobials. Purpose. Treat infections linked to tear-duct issues or recurrent otitis. Mechanism. Kills or inhibits bacteria locally. (Use only when diagnosed; specific products per culture/ENT/ophthalmology.) NCBI

12. Vitamin D (when deficient; see Supplements section)
    Class. Nutrient therapy. Purpose. Maintain bone health and immune function. Mechanism. Improves calcium-phosphate balance and skeletal mineralization. Safety. Avoid excess. Office of Dietary Supplements

13. Iron (when iron-deficiency is documented)
    Class. Nutrient therapy. Purpose. Correct anemia and support development. Mechanism. Restores hemoglobin and enzymes needing iron. Safety. Dose only when deficiency is confirmed. Office of Dietary Supplements

14. Nasogastric or gastrostomy tube feeds (medical nutrition therapy)
    Class. Not a drug—medical nutrition. Purpose. Ensure safe calories/fluids if oral intake is unsafe or inadequate. Mechanism. Bypasses swallowing challenges. NCBI

15. Other antiseizure medicines (if levetiracetam is not adequate or not tolerated—specialist guided)
    Purpose/Mechanism. According to seizure type and EEG; always titrated and monitored for side effects and interactions. NCBI

Note: Items above illustrate common, symptom-targeted medicines with strong FDA-label evidence for those indications; choice and dosing are individualized. There is no disease-specific FDA-approved therapy for SBBYS. NCBI

---

Dietary molecular supplements

Supplements do not treat SBBYS itself. Use only if your clinician recommends them after checking for deficiencies or interactions.

1. Vitamin D3 — supports bones/teeth; typical intakes for infants/children are 400–600 IU/day depending on age; avoid overdosing. Office of Dietary Supplements+1

2. Iron — only for proven deficiency; pediatric RDAs vary by age (e.g., 7–12 months: 11 mg/day). Office of Dietary Supplements

3. Omega-3 (DHA/EPA) — may support heart and neurodevelopmental health as part of diet; dosing varies; favor food first. Office of Dietary Supplements

4. Calcium — for bone health if intake is low; coordinate with vitamin D plan. Office of Dietary Supplements

5. Iodine — do not add unless deficiency is confirmed; thyroid care is guided by levothyroxine dosing, not casual iodine use. NCBI

6. Multivitamin (age-appropriate) — sometimes used when diet variety is limited; many children do not require one. AAP Publications

7. Fiber supplements — consider if constipation persists despite diet; use alongside fluids and behavioral plans. NCBI

8. Probiotics (select strains) — may help stool regularity in some children; evidence is mixed; discuss with GI. NCBI

9. Zinc — only if deficient; excessive zinc can cause copper deficiency. Office of Dietary Supplements

10. B-complex — food-first approach preferred; supplement only for confirmed needs to avoid imbalance. Office of Dietary Supplements

---

Immunity booster / regenerative / stem cell drugs

There are no approved “immunity-booster,” regenerative, or stem-cell drugs for Young–Simpson syndrome. The FDA warns that most “stem cell” products sold directly to patients are unapproved and potentially dangerous; the only FDA-approved stem-cell products are umbilical cord blood–derived hematopoietic progenitor cells for specific blood disorders—not for SBBYS or developmental conditions. If you see clinics advertising “stem cells” for genetic syndromes, that is not FDA-approved. Discuss only within the context of regulated clinical trials. U.S. Food and Drug Administration+2U.S. Food and Drug Administration+2

---

Surgeries

1. Ptosis/blepharophimosis repair (oculoplastic)
   Procedure. Eyelid surgery to improve opening and reduce vision blockage; tear-duct procedures if obstructed.
   Why. Prevent amblyopia, protect the cornea, and improve vision and function. NCBI

2. Cleft palate repair / velopharyngeal surgery
   Procedure. Team-based palate repair with speech therapy.
   Why. Improve feeding, ear health, and speech resonance. NCBI

3. Cardiac surgery (as indicated)
   Procedure. Repair of congenital heart defects by pediatric cardiac surgeons.
   Why. Prevent heart failure, improve oxygenation and growth. NCBI

4. Orthopedic procedures (knees/feet/contractures)
   Procedure. Tendon lengthening, osteotomies, or patella-related surgeries on a case-by-case basis.
   Why. Improve alignment, standing, and walking. NCBI

5. Orchiopexy (undescended testes)
   Procedure. Surgical placement of testes into the scrotum.
   Why. Protect fertility potential and reduce malignancy risk. NCBI

---

Practical preventions

1. Genetic counseling before future pregnancies—understand recurrence risk and testing options. NCBI

2. Prenatal and preimplantation genetic testing—possible when the familial KAT6B variant is known. NCBI

3. Structured surveillance plan—annual vision/hearing/thyroid/musculoskeletal checks catch problems early. NCBI

4. Vaccinations on schedule—protect against preventable infections that can worsen feeding and breathing. NCBI

5. Safe feeding practices—positioning, textures, and swallowing therapy reduce aspiration risk. NCBI

6. Dental hygiene and fluoride—reduce decay risk in hypoplastic or delayed-eruption teeth. NCBI

7. Sleep and airway screening—treat snoring/OSA to protect cognition and growth. NCBI

8. Sun-safety and eye protection—dry or exposed eyes benefit from careful protection and lubrication as advised. NCBI

9. Injury prevention with orthotics—stable mobility aids reduce falls and joint strain. NCBI

10. Care coordination—organized appointments reduce missed tests and delayed care. NCBI

---

When to see doctors (red-flag moments)

• Any feeding trouble (choking, poor weight gain) or vomiting/aspiration signs—pediatrician/GI promptly. NCBI

• Lethargy, constipation, cold intolerance in infants—screen thyroid early. NCBI

• Snoring, pauses in breathing, daytime sleepiness—sleep/ENT evaluation. NCBI

• Unusual movements or unresponsiveness—urgent seizure assessment. NCBI

• Cardiac symptoms (cyanosis, sweating with feeds, poor growth)—cardiology now. NCBI

• Eye concerns (constant tearing, crusting, eye redness, or droopy lids blocking pupils)—ophthalmology. NCBI

• New contractures, scoliosis, or pain with walking—orthopedics/physio. NCBI

---

What to eat and what to avoid

1. Prioritize balanced, calorie-appropriate meals with protein, fruits/vegetables, whole grains, and healthy fats to support growth. NCBI

2. Use texture-safe foods (guided by feeding therapy) to reduce aspiration. NCBI

3. Include vitamin-D and calcium sources (fortified milk/yogurt, safe sun per pediatric advice) or supplements if prescribed. Office of Dietary Supplements

4. Iron-rich foods (meat, legumes, iron-fortified cereals) if intake is low; supplements only for proven deficiency. Office of Dietary Supplements

5. Small, frequent meals if reflux is an issue; avoid late, large, spicy, or very acidic feeds near bedtime. FDA Access Data

6. Adequate fluids and fiber (fruits, vegetables, whole grains) for constipation prevention. NCBI

7. Avoid “immune-booster” or “stem cell” products sold online; these are not approved for SBBYS and may be dangerous. U.S. Food and Drug Administration

8. Be cautious with iodine-containing supplements—thyroid care is medication-guided, not supplement-guided. NCBI

9. Allergy-aware feeding—introduce new foods carefully per pediatric guidance. NCBI

10. Dietitian partnership—optimize calories/protein during illness or post-surgery recovery. NCBI

---

Frequently asked questions

1. Is Young–Simpson syndrome inherited?
   Usually it results from a new (de novo) KAT6B change; however, it is autosomal dominant, so an affected adult can pass it on. NCBI

2. How is the diagnosis confirmed?
   By clinical features plus genetic testing showing a heterozygous KAT6B pathogenic variant. NCBI

3. Is there a cure or disease-specific drug?
   No. Care is supportive and multidisciplinary, targeting each feature. NCBI

4. What specialists are needed?
   Pediatrics, genetics, cardiology, endocrinology, ophthalmology, ENT/audiology, orthopedics/physio, GI/nutrition, dentistry/craniofacial, and developmental services. NCBI

5. Will thyroid problems always be present?
   Not always, but hypothyroidism can occur and should be screened and treated early. NCBI

6. Are seizures common?
   Seizures can occur in some children; if present, they are managed with standard antiepileptic medicines under neurology. NCBI

7. What about heart defects?
   Congenital heart disease is possible; cardiology follow-up guides medicines or surgery. NCBI

8. Does it affect learning?
   Developmental delay/intellectual disability are common; early therapies and appropriate schooling help each child reach their potential. NCBI

9. Is growth affected?
   Feeding issues, cardiac effort, and endocrine factors can slow growth; careful nutrition and endocrine evaluation support catch-up. NCBI

10. Can surgery help with the eyelids or palate?
    Yes—ptosis/blepharophimosis repair and cleft palate repair are standard when indicated. NCBI

11. Are “stem cell” treatments available?
    No approved stem-cell or exosome therapies exist for SBBYS; FDA warns against unapproved clinics. U.S. Food and Drug Administration

12. What is the long-term outlook?
    Highly variable; with coordinated care, many complications can be managed, and quality of life improved. NCBI

13. Could another condition look similar?
    Yes—Genitopatellar syndrome overlaps; both are KAT6B-related and on a spectrum. NCBI

14. Where can families find trusted information and community?
    GeneReviews, MedlinePlus Genetics, Orphanet, NORD, and GARD provide reliable overviews and links. Genetic Rare Disease Center+4NCBI+4MedlinePlus+4

15. Can future pregnancies be tested?
    If the family’s KAT6B variant is known, prenatal or preimplantation genetic testing may be possible after counseling. NCBI

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 28, 2025.